A new article provides an overview of the global state of the field for using focused ultrasound to treat breast cancer.
The authors outlined ongoing research using several mechanisms of action and five devices and highlighted the technology’s ability to engage the immune system.
Focused ultrasound has the potential to become an alternative or complement to existing treatments in the management of breast cancer.
Professor Constantin Coussios is the Director of the Institute of Biomedical Engineering at the University of Oxford.
His team has overseen the clinical translation of several technologies into first-in-human trials, including kidney and liver ablation and drug delivery to treat solid tumors.
“There are mentors and there are sponsors – someone to share with you ideas about ways to carve out your path that you couldn’t even think of at your stage. Those kinds of influences are so important.”